prostate Cancer Awareness Month 2026

Written By Daniel Saddik

Prostate cancer is one of the most pressing health issues affecting men across Australia and New Zealand. This year alone, more than 26,000 Australian men are expected to be diagnosed, and the disease accounts for 13% of all cancer deaths, making it the second‑leading cause of cancer mortality after lung cancer. Countless others continue to navigate the ongoing realities of treatment, monitoring, and survivorship.

Urology & Prostate Cancer Awareness Month is a crucial moment to refocus attention on early detection, education, and the evolving role of imaging in improving outcomes. This month isn’t just about raising awareness - it’s about empowering men, families, clinicians, and communities with the knowledge and tools needed to detect prostate cancer earlier and manage it more effectively.

🌍 The Prostate Cancer Landscape

Prostate cancer is the most commonly diagnosed cancer in Australian men, and one of the leading cancers affecting men in New Zealand. While survival rates have improved significantly over the past decade, early detection remains the key differentiator in long‑term outcomes.

Key challenges include:

  • Low awareness of symptoms

  • Reluctance to seek medical advice

  • Variability in access to high‑quality imaging

  • Differences in specialist availability across metro and regional areas

Awareness Month helps break down these barriers by encouraging men to talk to their GP, understand their risk factors, and engage in regular screening conversations - especially those aged 50+, or 40+ with a family history.

🩻 Why Education in Prostate Imaging Matters

Modern prostate cancer care increasingly relies on advanced imaging, particularly Prostate MRI, to guide diagnosis, staging, and treatment planning. High‑quality MRI interpretation is now central to:

  • Detecting clinically significant prostate cancer

  • Reducing unnecessary biopsies

  • Improving targeted biopsy accuracy

  • Supporting active surveillance pathways

  • Enhancing multidisciplinary decision‑making

For Radiologists and Urologists, ongoing education in prostate imaging is essential. As MRI technology evolves and guidelines shift, clinicians need up‑to‑date training to ensure consistency, accuracy, and confidence in reporting.

This is especially important in Australia and New Zealand, where demand for prostate MRI continues to rise, and where regional access to subspecialty expertise can vary.

🧠 Introducing PROSTATERAD 2027: Advancing Prostate Imaging Excellence

To support clinicians in delivering the highest standard of prostate cancer diagnosis, we are proud to be hosting:

PROSTATERAD Imaging Workshop (27–28 February 2027 in Sydney)

Led by international experts, Professor Shonit Punwani (UK) and Clinical Associate Professor RaJeev Jyoti (Australia) this hands-on case review course focuses on prostate MRI interpretation and best practice in prostate imaging.

What PROSTATERAD Covers

  • PI‑RADS v2.1 interpretation

  • MRI anatomy & common diagnostic pitfalls

  • Case‑based learning with real clinical examples

  • Structured reporting

  • Integration of MRI findings into biopsy and treatment pathways

  • Multidisciplinary perspectives from Radiology and Urology

Whether you’re a Radiologist wanting to refine your reporting or a Urologist seeking deeper insight into MRI‑guided decision‑making, PROSTATERAD offers practical, clinically relevant education designed to elevate prostate cancer care across Australia and New Zealand.

💬 Join Us in February 2027

As prostate cancer rates continue to rise, the demand for highly skilled Radiologists has never been greater. PROSTATERAD 2027 is your opportunity to sharpen your expertise, connect with peers, and contribute to a future where every man receives the most accurate diagnosis possible.

Together, we can elevate prostate cancer care across Australia and New Zealand — one diagnosis at a time.

Learn more about prostaterad 2027

📣 Useful Resources

‍Here are some trusted, official sources to help clinicians, patients, and families learn more:‍ ‍

Australia

‍ New Zealand

‍WANT TO PLEDGE YOUR SUPPORT? ‍

Visit https://australianprostatecancer.org.au/awareness/

——-

Urology & Prostate Cancer Awareness Month is a reminder that early detection saves lives, and that high‑quality imaging is now one of the most powerful tools we have in the fight against prostate cancer. By investing in education, strengthening clinical pathways, and supporting men to seek care early, Australia and New Zealand can continue to improve outcomes for generations to come.

Daniel Saddik
Next

MSKRAD 2026 Highlights